| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |